Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 18, 2014

Primary Completion Date

October 16, 2019

Study Completion Date

October 16, 2019

Conditions

Human Immunodeficiency Virus

Interventions

DRUG

Aspirin

Daily Asprin daily

DRUG

Atorvastatin

Daily Atorvastatin Daily

Trial Locations (2)

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

Hennipen County Medical Center, Minneapolis

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT02081638 - Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study | Biotech Hunter | Biotech Hunter